These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37321369)

  • 1. Casein Reactivates Dopaminergic Nerve Injury and Intestinal Inflammation with Disturbing Intestinal Microflora and Fecal Metabolites in a Convalescent Parkinson's Disease Mouse Model.
    Pu Z; Liu S; Guo Z; Zhang X; Yan J; Tang Y; Xiao H; Gao J; Li Y; Bai Q
    Neuroscience; 2023 Aug; 524():120-136. PubMed ID: 37321369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.
    Liu X; Liu S; Tang Y; Pu Z; Xiao H; Gao J; Yin Q; Jia Y; Bai Q
    Neurochem Res; 2021 Jun; 46(6):1514-1539. PubMed ID: 33719004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
    Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
    Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
    Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
    Xu Z; Lian C; Pan L; Lai W; Zhang F; Peng L; Zhou S; Zhao G; Yang X; Zhang G; Tan Z; Wang Y
    Brain Res Bull; 2023 Oct; 202():110729. PubMed ID: 37579888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.
    Aktas B; Aslim B; Ozdemir DA
    Sci Rep; 2024 Jul; 14(1):15460. PubMed ID: 38965287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.
    Su Y; Liu N; Zhang Z; Li H; Ma J; Yuan Y; Shi M; Liu J; Zhao Z; Zhang Z; Holscher C
    Eur J Pharmacol; 2022 Jul; 926():175029. PubMed ID: 35584709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intestinal microbiota exerts a sex-specific influence on neuroinflammation in a Parkinson's disease mouse model.
    Zhou X; Gao Y; Wei J; Luo J; Wang Y; Yue M; Wang B; Hong D; Chen T; Fang X
    Neurochem Int; 2024 Feb; 173():105661. PubMed ID: 38157887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training has a protective effect in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model with improved neural and intestinal pathology and modified intestinal flora.
    Wang Y; Pu Z; Zhang Y; Du Z; Guo Z; Bai Q
    Behav Brain Res; 2023 Feb; 439():114240. PubMed ID: 36455673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Low-Protein, High-Carbohydrate Diet Exerts a Neuroprotective Effect on Mice with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson's Disease by Regulating the Microbiota-Metabolite-Brain Axis and Fibroblast Growth Factor 21.
    Chu C; Li T; Yu L; Li Y; Li M; Guo M; Zhao J; Zhai Q; Tian F; Chen W
    J Agric Food Chem; 2023 Jun; 71(23):8877-8893. PubMed ID: 37267589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroacupuncture may alleviate behavioral defects via modulation of gut microbiota in a mouse model of Parkinson's disease.
    Han QQ; Fu Y; Le JM; Pilot A; Cheng S; Chen PQ; Wu H; Wan GQ; Gu XF
    Acupunct Med; 2021 Oct; 39(5):501-511. PubMed ID: 33557583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration.
    Peng H; Yu S; Zhang Y; Yin Y; Zhou J
    Neurosci Bull; 2022 Aug; 38(8):871-886. PubMed ID: 35399136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
    Choi JG; Huh E; Ju IG; Kim N; Yun J; Oh MS
    J Neurol Sci; 2018 Sep; 392():77-82. PubMed ID: 30031172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT4 Receptor is Protective for MPTP-induced Parkinson's Disease Mice Via Altering Gastrointestinal Motility or Gut Microbiota.
    Cui C; Shi Y; Hong H; Zhou Y; Qiao C; Zhao L; Jia X; Zhao W; Shen Y
    J Neuroimmune Pharmacol; 2023 Dec; 18(4):610-627. PubMed ID: 37782386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twice subacute MPTP administrations induced time-dependent dopaminergic neurodegeneration and inflammation in midbrain and ileum, as well as gut microbiota disorders in PD mice.
    Xie W; Gao J; Jiang R; Liu X; Lai F; Tang Y; Xiao H; Jia Y; Bai Q
    Neurotoxicology; 2020 Jan; 76():200-212. PubMed ID: 31790727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice.
    Wang B; Geng L; Wang J; Wei Y; Yan C; Wu N; Yue Y; Zhang Q
    Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
    Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
    Yang C; Wang W; Deng P; Wang X; Zhu L; Zhao L; Li C; Gao H
    CNS Neurosci Ther; 2023 Dec; 29(12):3815-3828. PubMed ID: 37334756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.